See more : Shree Ajit Pulp and Paper Limited (SAPPL.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Jushi Holdings Inc. (JUSHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jushi Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Pomvom Ltd (PMVM.TA) Income Statement Analysis – Financial Results
- City of London Investment Group PLC (CLIUF) Income Statement Analysis – Financial Results
- Orient Securities International Holdings Limited (8001.HK) Income Statement Analysis – Financial Results
- Zeng Hsing Industrial Co., Ltd. (1558.TW) Income Statement Analysis – Financial Results
- Next Capital Public Company Limited (NCAP.BK) Income Statement Analysis – Financial Results
Jushi Holdings Inc. (JUSHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jushico.com
About Jushi Holdings Inc.
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabidiol supplements, tinctures, capsules, softgels, and topicals under The Bank, The Lab, Nira+ Medicinals, Seche, Tasteology, and Nira brands. As of June 6, 2022, it operated 33 BEYOND/HELLO retail locations. The company was incorporated in 2007 and is headquartered in Boca Raton, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 269.45M | 284.28M | 209.29M | 80.77M | 10.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 153.22M | 188.81M | 121.92M | 37.70M | 5.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 116.23M | 95.48M | 87.37M | 43.07M | 4.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 43.14% | 33.59% | 41.75% | 53.32% | 47.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 315.63K | 914.63K | 1.23M | 1.42M | 3.04M | 1.75M | 26.77K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.96K | 0.00 | 113.04K | 194.52K | 165.85K | 228.23K | 0.00 | 0.00 |
SG&A | 110.47M | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 336.59K | 914.63K | 1.23M | 1.42M | 3.21M | 1.98M | 26.77K | 37.12K |
Other Expenses | 8.57M | -482.00K | 6.84M | 5.07M | 2.16M | 0.00 | 0.00 | 1.17K | 37.70K | 279.10K | 134.92K | 155.94K | 30.32K | 0.00 | 0.00 |
Operating Expenses | 119.05M | 156.17M | 108.53M | 51.49M | 35.50M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
Cost & Expenses | 272.26M | 344.97M | 230.45M | 89.19M | 40.90M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
Interest Income | 0.00 | 142.00K | 243.00K | 231.00K | 378.49K | 1.07M | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 0.00 | 156.00 | 0.00 |
Interest Expense | -36.97M | 45.73M | 31.20M | 19.13M | 3.25M | 0.00 | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 2.66K | 156.00 | -37.12K |
Depreciation & Amortization | 27.08M | 26.49M | 8.41M | 4.43M | 2.23M | -15.37K | 7.72K | -3.40M | 15.12K | 17.26K | 14.79K | 18.46K | 11.69K | -156.00 | 0.00 |
EBITDA | 30.91M | -121.65M | -10.89M | -7.10M | -38.64M | -142.51K | -72.64K | -3.74M | -944.29K | -1.50M | -1.50M | -3.31M | -2.00M | -26.77K | -37.12K |
EBITDA Ratio | 11.47% | -12.15% | -5.20% | -8.79% | -239.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -2.82M | -60.69M | -20.36M | -8.42M | -30.67M | -127.15K | -80.36K | -337.76K | -952.32K | -1.50M | -1.58M | -3.40M | -2.01M | -26.62K | -37.12K |
Operating Income Ratio | -1.05% | -21.35% | -9.73% | -10.43% | -299.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -31.09M | -113.34M | 88.22M | -185.34M | 7.89M | 15.37K | 7.72K | -3.40M | 19.60K | 28.83K | 48.10K | 92.24K | 0.00 | 0.00 | 0.00 |
Income Before Tax | -33.91M | -193.88M | 52.45M | -201.47M | -26.26M | -111.78K | -72.64K | -3.74M | -932.72K | -1.47M | -1.53M | -3.31M | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | -12.58% | -68.20% | 25.06% | -249.42% | -256.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 32.39M | 8.45M | 31.09M | 10.40M | 4.51M | -15.37K | -7.72K | 3.40M | -39.20K | -75.87K | -33.58K | -115.26K | -5.31K | -312.00 | 37.12K |
Net Income | -66.30M | -202.32M | 20.25M | -211.87M | -30.77M | -111.78K | -64.92K | -7.14M | -932.72K | -1.47M | -1.53M | -3.31M | -2.01M | -26.62K | -37.12K |
Net Income Ratio | -24.60% | -71.17% | 9.68% | -262.30% | -300.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.34 | -1.06 | 0.12 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
EPS Diluted | -0.34 | -0.99 | -0.41 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
Weighted Avg Shares Out | 194.77M | 190.02M | 170.29M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
Weighted Avg Shares Out (Dil) | 194.77M | 204.24M | 201.61M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
Here Are 3 Marijuana Stocks For Cannabis Investors To Watch Right Now
Jushi Holdings Inc. to Report Third Quarter 2023 Financial Results on November 14, 2023
Top Marijuana Stocks For Cannabis Investing 2024
3 Marijuana Stocks To Buy Last Week Of October
Top US Marijuana Penny Stocks to Watch Before November 2023
Top 3 Performing Marijuana Stocks In the Last Six Months
Top Marijuana Stocks To Watch Before The Start Of 2024
Mid-October's Leaders: Best-Performing Marijuana Penny Stocks of 2023
Steps To Investing In Marijuana Stocks Today
Picking Winners: Top US Cannabis Stocks to Watch in 2023
Source: https://incomestatements.info
Category: Stock Reports